Swedish Biotech Believes Second Time is the Charm for Rabeximod Cyxone, a small biotech company from Sweden, is trying to take their investigational drug into a market that is potentially worth $36.11...
Roche Acquires Inflazome for $449 Million Swiss Pharmaceutical company, Roche, has finalized plans to close a share purchase agreement with Irish biotech company Inflazome. Inflaz...
Amgen's KRAS Inhibitor Reduces Non-Small Cell Lung Cancer in a Phase I Clinical Trial Amgen is pulling the curtain on full data after releasing small snippets about its keenly watched KRAS inhibitor. The drug, tagged Sotora...
Chi Med Submits New Drug Application for Surufatinib to Treat Pancreatic Cancer Chinese biotech company Hutchison China MediTech, popularly known as Chi-Med, on Thursday announced that its Second NDA for Surufatinib f...
Marinus Pharmaceuticals Meets Phase 3 Endpoints for Epilepsy Marinus Pharmaceuticals, Inc., a pharmaceutical firm dedicated to developing innovative therapeutics to treat rare seizure disorders, ann...
I-Mab Partners with AbbVie to Develop and Commercialize an anti-CD47 mAb Chinese biotech, I-Mab, has signed a deal with AbbVie for the development and commercialization of I-Mab’s highly differentiated anti-CD4...
Aug 27 2 min Russian Roulette: A Plasma Treatment Without Efficacy is Playing Politics On August 23, 2020, The President of the United States and FDA announced an 'emergency authorization' of a drug that will be used as a tr...
Aug 14 3 min Living with SARS The Covid-19 pandemic has shown us that the world is never, at any time, safe. And thanks to the outbreak, scientists around the world ha...
Jun 12 4 min Insulin Drug Prices Turns Lethal for a Patient Rationing to Pay Rent Over the past several years there have been many horror stories about the USA healthcare system. Everything from the rising cost of prem...
a day ago 2 min Roche Acquires Inflazome for $449 Million Swiss Pharmaceutical company, Roche, has finalized plans to close a share purchase agreement with Irish biotech company Inflazome. Inflaz...
Sep 13 2 min Telehealth Giant Amwell Sets Initial Public Offering at $560 Million American Well Corporation is gearing up to go public, telehealth provider Amwell has released terms of its upcoming IPO in a regulatory d...
Sep 6 2 min Lixte Biotechnologies Needs $11 Million From Investors to Push Them to Phase 2 OTC-listed Lixte Biotechnology Holdings filed last Thursday with the SEC to uplist to Nasdaq, raising $11 million in an initial public of...
an hour ago 2 min Swedish Biotech Believes Second Time is the Charm for Rabeximod Cyxone, a small biotech company from Sweden, is trying to take their investigational drug into a market that is potentially worth $36.11...
5 days ago 2 min Amgen's KRAS Inhibitor Reduces Non-Small Cell Lung Cancer in a Phase I Clinical Trial Amgen is pulling the curtain on full data after releasing small snippets about its keenly watched KRAS inhibitor. The drug, tagged Sotora...
Sep 2 2 min Aimmune Acquired by Nestle for $2.6 Billion Aimmune (AIMT) a biopharmaceutical startup agreed to be acquired by Nestle for $2.6 Billion or $34.50 dollars a share. Before the acquisi...
